Unable to display view head.php file not found.
This Figure illustrates the crude incidence rates of fatal and non-fatal bleeding, from the previous Figure, according to antithrombotic regimen per time period following enrollment. The results clearly show that the patients on triple therapy have a much higher bleeding rate than do patients on other combinations of antiplatelet and antithrombin therapies.[134]
French WJ. Am J Med 2013; 126: 00-00.
[134] Lamberts M, Olesen JB, Ruwald MH, et al. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Circulation. 2012;126:1185-1193.